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Abstract Apoptosis has been suggested to have an important role in the pathogenesis of rest-
enosis in addition to cell migration and proliferation. The aim of the present study was to in-
vestigate in an experimental in vivo model the occurrence of apoptosis postangioplasty and its
relation to bcl-2 and peroxynitrite detection.
Eighteen hypercholesterolemic rabbits underwent transluminal angioplasty of the right iliac
artery. The rabbits were sacrificed on the 1st, 2nd, 3rd, 7th, 15th, and 28th day postangio-
plasty (3 animals per time point) and both the angioplasted and non-injured arteries were
studied. Apoptosis was assessed by the terminal uridine nick-end labeling method (TUNEL).
Bcl-2 and peroxynitrite were detected by immunochemistry using anti-bcl-2 and anti-nitrotyr-
osine antibodies.
In the angioplasted arteries the number of apoptotic cells was 1% of the total cell popula-
tion in both media and neointima at any of the postangioplasty time points examined. Bcl-2
and nitrotyrosines were detected at all time points in the angioplasted arteries (vs. non-
injured, P < 0.001), showed similar localization and had the same peaks of expression both
in the media (7th day: Bcl-2 66% and nitrotyrosines 74%) and neointima (15th day: Bcl-2 67%
and nitrotyrosines 61%).
In this experimental model we observed low apoptotic rates while bcl-2 and peroxynitrite
products were detected. We can hypothesize that the detection of nitrotyrosines is related
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Apoptosis, bcl-2 and nitrotyrosines in restenosis 261with reduced levels of nitric oxide resulting in increased expression of the bcl-2, preventing
thus cell death due to either apoptosis or necrosis. Further studies are needed in order to elu-
cidate their role in the restenosis process.
ª 2007 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Restenosis rates, after percutaneous transluminal angio-
plasty, range from 16e42% with neointimal formation being
one of the main mechanisms.1e3 Previous studies have em-
phasized the pivotal roles of vascular smooth muscle cells
(VSMCs) proliferation and migration as well as extracellular
matrix accumulation in the postangioplasty neointimal for-
mation.4e8 In addition to these, apoptosis of VSMCs has
been suggested to be an important factor in the pathogen-
esis of restenosis, although the triggering mechanisms are
currently unknown.9e13 It should be also noted that the ap-
optosis’ rates in the published reports vary widely and
range from <1% to >50%. It is also known that bcl-2 is in-
volved in regulating VSMCs apoptosis and more specifically
its overexpression can inhibit apoptosis of VSMCs.14,15
There has been considerable interest regarding the role
of nitric oxide (NO) in postangioplasty restenosis.16,17 NO
can both induce and inhibit apoptosis of VSMCs depending
upon the different redox state of the NO once released
from the cells.18,19 The anti-apoptotic activity of NO has
been related with the increase of the bcl-2 expression,
the inhibition of bax overexpression and the S-nitrosylation
of caspases. It has also been found that NO can upregulate
bax, possibly via p53 upregulation resulting thus in apopto-
sis. Superoxide anion (O2) is another factor that is involved
in the process of vascular cell proliferation and neointimal
growth.15,20 The reaction of NO with O2 forms peroxyni-
trite (ONOO) and nitrated tyrosine residues (nitrotyro-
sines) represent an in vivo footprint marker of ONOO.21,22
In the present study we used a hypercholesterolemic
iliac rabbit model to investigate the expression of bcl-2 in
relation to nitrotyrosine formation in order to elicit
evidence for the anti-apoptotic activity of NO in the
restenosis process. We also investigated the occurrence of




Eighteen (male) New Zealand white rabbits (mean body
mass 3.0 kg) housed in individual cages constituted the
study material. Animals were fed a chow diet with choles-
terol supplementation (92% chow, 2% cholesterol and 6%
peanut oil) over a five week period, leading to high serum
cholesterol levels (mean  SD: 1050  540 mg/dl). All ani-
mals received humane care in compliance with the ‘‘Guide
for the Care and Use of Laboratory Animals’’ published by
the National Institutes of Health 5377-3, (Washington:
National Academy Press; 1996) and the animal protocol
was approved by the Institutional Animal Care and Use
Committee of the University of Ioannina, Greece.Angioplasty
Balloon angioplasty was carried out at the right iliac artery
of all eighteen rabbits during the first day of the sixth week
period. Under general anesthesia (ketamine HCl: 35 mg/kg,
midazolam 5 mg/kg and atropine 150 mg/kg) the right fem-
oral artery was surgically exposed in each animal and
a transverse arteriotomy was performed to its distal part.
A modified Baumgartner technique was used for balloon an-
gioplasty. More specifically, a 2.5 mm diameter centering
balloon, 20 mm in length, was inserted into the lumen of
the artery and advanced into the right iliac artery. The bal-
loon was then inflated at 10 Atm over a 2 min long period.
Clips were positioned at the muscles adjacent to the prox-
imal and distal injury sites. The balloon catheter was then
deflated and withdrawn, the artery was repaired surgically
and the subcutaneous tissue was closed. After angioplasty
a standard diet without cholesterol supplementation was
fed to the animals.
Tissue preparation and analysis
The animals were euthanized on the 1st, 2nd, 3rd, 7th, 15th
and 28th day after angioplasty (3 animals per time point).
The balloon dilated right iliac arteries (angioplasty group)
and the left non-injured iliac arteries (control group)
were studied in each animal. Sixty minutes before perfu-
sion-fixation the rabbits were infused intravenously with
60 mg/kg of Evans blue dye in PBS.
After application of a lethal dose of sodium phenobar-
bital, a thoracotomy was performed and the entire vascu-
lature was fixed in situ with perfusion of 500 ml of 10%
neutral buffered formalin solution via a catheter inserted
into the left ventricle. After 15 min of perfusion-fixation
the right (angioplasted) and the left (non-injured) arteries
were excised and fixed in the same fixative for 4 to 6 h.
Two to three cross sections were taken from the central
de-endotheliazed region of each right iliac artery stained
blue which probably represented the middle of the de-
nuded and dilated arterial segment. Cross sections at
2 mm intervals were also taken from the non-injured left
iliac arteries (control group).
The samples were routinely processed in grading ethanol
and embedded to paraffin. Serial tissue sections (5 mm
thick) were then cut. Two slides (2e3 sections/slide) from
each block were stained with hematoxylin-and-eosin
(H&E) and Masson trichrome stain respectively for the ini-
tial morphological evaluation and the others were used
for further immunohistochemical and apoptosis analyses.
Immunohistochemical analysis
The indirect avidin-biotin horseradish peroxidase complex
method was applied for all the immunohistochemical
stains, as it has been described previously. As primary
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(1A4, DAKO), macrophage CD68 (KP1, DAKO) Von Wille-
brand Factor (F8/86, DAKO) and CD34 (Becton-Dickinson)
were used for the identification of VSMCs, macrophages and
endothelial cells respectively. Bcl-2 protein expression and
peroxynitrite generation were demonstrated by using the
bcl-2 (124, DAKO) and anti-nitrotyrosine (ZUO5-233, TCS)
monoclonal antibodies respectively. Positive control slides
were included in all tests and negative control slides were
prepared by omitting the primary antibodies.
Bcl-2 expression was also determined by the percentage
of the ratio of positive cells with cytoplasmic staining to the
total number of cells counted. Nitrotyrosines expression
was assessed by the percentage of the ratio of positive cells
with intracellular staining (mainly cytoplasmic and rarely
nuclear) to the total number of cells counted.
TUNEL assay
The in-situ visualization of DNA fragmentation was per-
formed on paraffin sections (5 mm thick) placed on super-
frost slides using the commercial end-labeling Apop Tag
Peroxidase Kit (Oncor). After deparaffinization and dehy-
dration, slides were rinsed in phosphate buffer solution
(PBS, pHZ 7.2). Tissue sections were then digested by in-
cubation for 20 min with proteinase K (20 mg/ml, Oncor)
at room temperature and then were rinsed in distilled
water.
The peroxidase activity was blocked by incubation for
5 min in 2% hydrogen peroxide in PBS. After the application
of an equilibration buffer, slides were incubated in work-
ing-strength TdT enzymes that contained dUTP-digoxigenin
for 1 h at 37 C. The reaction was stopped by a pre-warmed
at 37 C working-strength stop/wash buffer and then slides
were rinsed in PBS. The incorporated nucleotides were
identified by adding peroxidase conjugated anti-digoxige-
nin antibody and visualized with 3,30-diaminobenzidine
tetra-hydrochloride (DAB, Oncor). Counterstaining was
performed with Harris’ hematoxylin. Negative control
slides were prepared by omitting the TdT reaction step.
Germinal centers of human lymph nodes served as positive
controls.
To determine the apoptotic index light microscopic
examination of each artery in both groups (angioplasty
and control) at a magnification of 400 was carried out by
two experienced pathologists. Separate calculations were
done for neointima and media in each artery of the
angioplasty group of animals. The apoptotic index was
determined from the percentage of the ratio of TUNEL
positive nuclei to the total number of cells counted (at
least 1000 cells per artery were counted).
Statistical analysis
The results were expressed as mean values  SD. The
comparisons of TUNEL, Bcl-2 and nitrotyrosines expression
at each time point with their representative controls (non-
injured arteries) were performed by non-parametric
ManneWhitney U-test. Differences were considered to be
significant at a value of P < 0.05 as determined with
SPSS 11.0 Software (SPSS, Inc, Chicago, IL).Figure 1 (A) Masson trichrome stain from a non-injured left
iliac artery (3rd postangioplasty day, original magnification
330). (B) Masson trichrome stain from a right iliac artery with
angioplasty. The formation of neointima (NI) is obvious. (7th
postangioplasty day, original magnification 330). (C) Avidin-
biotin method for CD34 (identification of endothelial cells)
shows the formation of neointima (NI) and reendothelization
(15th postangioplasty day, original magnification 660).
Apoptosis, bcl-2 and nitrotyrosines in restenosis 263Table 1 Bcl-2, TUNEL and Nitrotyrosines expression at time points examined in media and neointima (data are expressed as
mean (SD) %)
Bcl-2 media Bcl-2 neointima TUNEL media TUNEL neointima Nitrotyrosines media Nitrotyrosines neointima
Day 1 8.0 (0.4) e 0.9 (0.2) e 7.5 (6.4) e
Day 2 13.8 (8.8) e 1.0 (0.4) e 10.2 (8.8) e
Day 3 50.0 (14.1) e 0.8 (0.2) e 47.5 (10.6) e
Day 7 65.9 (17.2) 20.7 (35.8) 0.3 (0.4) 0.5 (0.2) 74.0 (22.6) 60.0 (12.4)
Day 15 64.0 (8.0) 67.2 (13.4) 0.9 (0.3) 0.5 (0.4) 65.7 (14.6) 61.3 (9.3)
Day 28 56.2 (6.5) 51.0 (13.7) 0.3 (0.3) 0.2 (0.3) 47.3 (20.2) 44.7 (14.2)Results
Morphological results
1st postangioplasty day
In the angioplasted arteries extensive loss of endothelial
cells was observed in H&E stained sections and confirmed
using immunohistochemical stains for VWF and CD34 anti-
gen. Also extensive damage with reduction of VSMCs was
seen in the media by H&E, Masson and smooth muscle actin
(SMA)-immunostain.
2nd and 3rd postangioplasty days
The loss of endothelial cells remained as a consistent
finding, whereas restoration of media started with an
increasing number of VSMCs.
7th postangioplasty day
Neointima formation consisted of VSMCs with a small
amount of extracellular matrix was demonstrated by
Masson and SMA-immunostain (Fig. 1B).
15th postangioplasty day
Increase of neointima thickening and reendothelization was
noted. The increase of neointima thickening was composed
of VSMCs, macrophages and extracellular matrix (H&E,
Masson, CD34, CD68 and SMA-immunostains; Fig. 1C).
28th postangioplasty day
Further increase of neointimal thickening was seen.
All arteries were atherosclerotic at the time of angio-
plasty. The left iliac arteries (control group) did not show
any significant morphological changes at 28th postangio-
plasty day except for few foam cells occasionally found in
the media or subendothelially (Fig. 1A).
Quantification of apoptosis
In non-injured arteries apoptotic cell nuclei detected by
TUNEL in 0.2  0.2%. In the angioplasted arteries the TUNEL-
positive cells remained at a very low level (<1%) in both
media and neointima at any of the postangioplasty time
points examined (Table 1, Figs. 2, 4 and 5).
Bcl-2 and Nitrotyrosine expression
In non-injured arteries Bcl-2 was present in 0.3  0.3%. In
angioplasted arteries Bcl-2 protein was observed at all
time points (Table 1). The expression reached its peak inthe media at the 7th day (65.85  17.18%, P < 0.001) and
in the neointima at the 15th day (67.2  13.4%, P < 0.001;
Figs. 4 and 5). The Bcl-2 staining was cytoplasmic and was
seen mainly in the neointima and media (Figs. 3A,C).
In non-injured arteries nitrotyrosines were present in
0.2  0.3%. In angioplasted arteries were also observed dur-
ing all studied time points (Table 1) with the peak of ex-
pression in the media and neointima been at the 7th
(74.0  22.6%, P < 0.001) and at the 15th postangioplasty
day (61.3  9.3, P < 0.001; Figs. 4 and 5) respectively.
Nitrotyrosines was mainly seen in the cytoplasm and rarely
intranuclear. Extracellular positive staining was observed
only in the more damaged segments of the vascular wall
(Figs. 3B,D).
Discussion
There is increasing evidence that apoptosis is involved in
the restenotic process. In previous experimental studies the
percentages of apoptotic cells in the restenotic lesions vary
from <1% to >50%9,11,12,23e25 with the higher percentages
seen when tissue was analyzed during the first hour postan-
gioplasty.13,26 Although, there is a controversy on the apo-
ptosis’ rate, most studies conclude that both responses
(VSMC proliferation and apoptosis) co-exist in the neoin-
tima. The variance in the apoptotic rates reported in the
literature is possibly due to the fact that tissue analysis
occurred at different postangioplasty time points. In our
study the number of apoptotic cells was 1% of the total
cell population in both media and neointima at any of the
Figure 2 TUNEL-positive cells in the media (M) and in the
secondary thrombus (2nd postangioplasty day, original magnifi-
cation 660).
264 I.K. Toumpoulis et al.Figure 3 (A) Avidin-biotinmethod for Bcl-2 with increased ex-
pression in the media (M). (3rd postangioplasty day, original
magnification160). (B) Avidin-biotin method for nitrotyrosines
with increased expression in themedia (M). Of note is the similar
localization and distribution of Bcl-2 (Fig. 3A) and nitrotyrosines
in the same arterial segment (3rd postangioplasty day, original
magnification 160). (C) Avidin-biotin method for Bcl-2 withpostangioplasty time points been examined, although it
should be noted that the first tissue analysis occurred
24 h postangioplasty.
Bcl-2 proto-oncogene inhibits apoptotic deaths being
induced by diverse stimuli. The protein products of the bcl-
2 gene family are localized in intracellular sites where
oxygen free radicals are generated (e.g. mitochondria,
endoplasmic reticula and nuclear membranes). In vitro
studies have shown that bcl-2 overexpression suppresses
membrane lipid peroxidation which represents an early
step of the apoptotic cell death being induced by reactive
oxidizing factors. Thus, it is suggested that bcl-2 regulates
an antioxidant pathway at sites of free radical generation.
This antioxidant function of bcl-2 is attributed to its ability to
prevent the harmful effects of oxidative stress in the cellular
components, although bcl-2 does not stop free radical
generation.27 Currently bcl-2 was detected as early as the
1st postangioplasty day and reached thepeakof their expres-
sion at day 7 in the media and at day 15 in the neointima. At
all time points that bcl-2 was examined was higher at the an-
gioplasted arteries compared with the controls. Our results
(increased bcl-2 expression at sites with low apoptosis) are
in concordance with the above findings.
It is known that NO is a ubiquitous molecule, that acts as
an intracellular and extracellular messenger and has both
deleterious and beneficial effects on the target cells. NO
regulates the expression of genes involved in the apoptotic
cell death and in high concentrations causes apopto-
sis.18,19,28 NO toxicity is enhanced by producing ONOO
after reacting with O2.29 Peroxynitrite (ONOO) not only
inhibits the normal homeostatic function of NO (e.g. regu-
lation of vasomotor tone, regulation of proliferation and
cell migration, induction of cytoprotective genes and mod-
ulation of cytotoxicity by activated macrophages and toxic
cytokine production) but also causes cellular damage as it is
a strong oxidant. Peroxynitrite can be detected in biological
samples indirectly by measuring tyrosine residues nitration
(nitrotyrosines).21,22,30 Currently peroxynitrite biological
products (nitrotyrosines) were detected as early as the 1st
postangioplasty day and reached the peak of their expres-
sion at day 7 in the media and at day 15 in the neointima.
According to our results the staining for nitrotyrosines and
Bcl-2 proteins had analogous peaks of expression in the me-
dia and neointima (Figs. 4 and 5) and showed similar locali-
zation and distribution in the studied arterial segments
(Fig. 3). We can speculate that bcl-2 overexpression in the
media and neointima might render them resistant against
the toxic effects of peroxynitrite and generally of the oxida-
tive stress preventing thus cell death due to either apoptosis
or necrosis. We can also hypothesize that the detection of
nitrotyrosines is related with reduced levels of NO (NO
is consumed in the reaction with O2) resulting thus in
increased levels of Bcl-2 protein.18
Our findings suggest that nitrotyrosines in the 1st
postangioplasty day can be formed despite the lack of
endothelial cells and therefore of endothelial NO synthase.
increased expression in the media (M) and neointima (NI).
(15th postangioplasty day, original magnification 330). (D)
Avidin-biotin method for nitrotyrosines shows positive cells
both in the media (M) and neointima (NI). (15th postangioplasty
day, original magnification 660).

















Figure 4 Bcl-2, TUNEL and nitrotyrosines expression at all time points examined in media.Preliminary results from our study (data not shown) suggest
that a kind of inducible NO synthase is produced by VSMCs
immediately after the angioplasty procedure. These find-
ings are in concordance with recently reported data.31
The present study has several limitations. First, the
experimental model been used is a non-stenting one and
therefore, the results are only applicable to restenosis
after plain balloon angioplasty. Second, for apoptosis
detection the TUNEL method was used, which has a reduced
specificity in cases with increased cell proliferation rates.
Third, currently we used a 4-week time point, starting 24 h
postangioplasty. Earlier time course experiments may pro-
vide additional information regarding apoptosis rates and
detection of bcl-2 and nitrotyrosines. Finally, we could
not use DNA electrophoresis or Western blot analysis be-
cause our tissue samples were needed for histological and
immunohistological analysis in order to evaluate apoptosisand expression of bcl-2 and nitrotyrosines. Forth, the re-
sults of the present may be different whether cholesterol
supplementation used during the postangioplasty period.
Conclusion
Apoptosis as measured with TUNEL method practically does
not occur after angioplasty in restenotic lesions. Bcl-2 and
peroxynitrite products (nitrotyrosines) are detected at all
times points postangioplasty, while their expression and
localization in the restenotic lesions are similar. Oxidative
stress occurs after angioplasty leading to an increase in
peroxynitrite, and that increased bcl-2 expression counter-
acts this oxidative stress, preventing apoptosis and cell
death. Further studies are needed in order to elucidate

















Figure 5 Bcl-2, TUNEL and nitrotyrosines expression at all time points examined in neointima.
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